Wavestone S.A. (WAVE)
Euronext Paris · France · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 30.10 |
|---|---|
| 52-week range | 28.50 – 63.70 |
| Return, 1 month / 3 months | +4.0% / −22.4% |
| Return, 1 year / 3 years | −39.1% / −24.4% |
| Trend | Below its 200-day average |
| RSI (14) | 49 |
| Volatility (1 year) | 55.5% |
| Worst drawdown (1 year) | -52.5% |
| Average daily value traded | 1.06M EUR |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Wavestone is a consulting firm based in France that advises large organisations on digital transformation, information technology strategy and operational performance. Its consultants work with clients in sectors such as banking, insurance, manufacturing, energy, retail and the public sector, helping them plan and deliver changes to their systems and ways of working. The firm operates from offices in France and other countries, serving businesses and public bodies that need guidance on technology and management issues.
Wavestone S.A. trades under the code WAVE on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Wavestone S.A. (WAVE) trades on the Euronext Paris in France. It last closed at EUR 30.10 on 19 October 2026.
Its price-based Market X-Ray is 31 out of 100 (a weak price profile), ranking 497 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 39.1% and over the last three months it fell 22.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 15 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -28.2% | ||
| From 52-week high | -50.6% | ||
| Momentum | 17 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -22.4% | ||
| 6-month return | -34.3% | ||
| 12-month return, skipping the last month | -41.4% | ||
| Stability (higher is calmer) | 30 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 55.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -52.5% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 1.06M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 36 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.3% |
|---|---|
| 1 month | +4.0% |
| 3 months | −22.4% |
| 6 months | −34.3% |
| 1 year | −39.1% |
| 3 years | −24.4% |
| 5 years | −34.7% |
Signals
| 50-day / 200-day average | 31.31 / 41.90 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.89 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Aug 2026 | EUR 0.5000 |
| 4 Aug 2025 | EUR 0.4600 |
| 31 Jul 2024 | EUR 0.3800 |
| 2 Aug 2023 | EUR 0.3800 |
| 3 Aug 2022 | EUR 0.3800 |
| 2 Aug 2021 | EUR 0.2300 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.